NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that it doubled its revenues in the first quarter, driven by strong growth in its molecular information services to biopharmaceutical companies.

For the three months ended March 31, the Cambridge, Massachusetts-based firm reported $52.8 million in revenues, up from $26.3 million during the same period last year and beating the average Wall Street revenue estimate of $44.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.